DIVERSA is a biotechnology company promoting the transfer to the clinic of new therapeutic molecules through the application of drug delivery nanotechnology. We want to build a bridge between molecules and patients, between drug discovery and clinical application. DIVERSA aspires to become the company of reference for drug delivery, opening new opportunities for innovative medicines and improving patients’ lives.

With our patented technology of nanometric lipid emulsions, we can efficiently bind new drug molecules and transport them to their place of action in their therapeutically active form, so that they can be effective and thus generate new opportunities for drug discovery. It is the most versatile and simple platform on the market, and we have demonstrated its ability to associate and release both biomolecules (proteins, peptides, aptamers, antibodies, DNA or RNA) and hydrophobic small molecules.